164 related articles for article (PubMed ID: 33363381)
1. UBE2N Regulates Paclitaxel Sensitivity of Ovarian Cancer via Fos/P53 Axis.
Zhu Q; Chen J; Pan P; Lin F; Zhang X
Onco Targets Ther; 2020; 13():12751-12761. PubMed ID: 33363381
[TBL] [Abstract][Full Text] [Related]
2. ERp57‑small interfering RNA silencing can enhance the sensitivity of drug‑resistant human ovarian cancer cells to paclitaxel.
Li S; Zhao X; Chang S; Li Y; Guo M; Guan Y
Int J Oncol; 2019 Jan; 54(1):249-260. PubMed ID: 30431082
[TBL] [Abstract][Full Text] [Related]
3. UBE2N Promotes Melanoma Growth via MEK/FRA1/SOX10 Signaling.
Dikshit A; Jin YJ; Degan S; Hwang J; Foster MW; Li CY; Zhang JY
Cancer Res; 2018 Nov; 78(22):6462-6472. PubMed ID: 30224375
[TBL] [Abstract][Full Text] [Related]
4. HIF Inactivation of p53 in Ovarian Cancer Can Be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity.
Parmakhtiar B; Burger RA; Kim JH; Fruehauf JP
Mol Cancer Res; 2019 Aug; 17(8):1675-1686. PubMed ID: 31088908
[TBL] [Abstract][Full Text] [Related]
5. Capilliposide from
Zhang K; Ying H; Zhao R; Chen Y; Deng Q
Chin Herb Med; 2022 Jan; 14(1):111-116. PubMed ID: 36120123
[TBL] [Abstract][Full Text] [Related]
6. A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways.
Cheng J; Fan YH; Xu X; Zhang H; Dou J; Tang Y; Zhong X; Rojas Y; Yu Y; Zhao Y; Vasudevan SA; Zhang H; Nuchtern JG; Kim ES; Chen X; Lu F; Yang J
Cell Death Dis; 2014 Feb; 5(2):e1079. PubMed ID: 24556694
[TBL] [Abstract][Full Text] [Related]
7. SP1 transcriptionally regulates UBE2N expression to promote lung adenocarcinoma progression.
Li J; Qi C; Shao S; Chen Y; Peng Z; Shen Q; Zhang Z
Mol Biomed; 2023 Mar; 4(1):7. PubMed ID: 36964266
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling analysis of ovarian cancer.
Yin JG; Liu XY; Wang B; Wang DY; Wei M; Fang H; Xiang M
Oncol Lett; 2016 Jul; 12(1):405-412. PubMed ID: 27347159
[TBL] [Abstract][Full Text] [Related]
9. CRTC2 promotes paclitaxel resistance by inducing autophagy in ovarian cancer in part via the PI3K-AKT signaling axis.
Ou C; Peng C; Wang Y; Lu S; Yu X; He Q; He A; Zhang L
J Cancer; 2023; 14(6):1011-1023. PubMed ID: 37151390
[No Abstract] [Full Text] [Related]
10. CPEB4-Promoted Paclitaxel Resistance in Ovarian Cancer
Zhang Y; Gan H; Zhao F; Ma X; Xie X; Huang R; Zhao J
Front Pharmacol; 2020; 11():600994. PubMed ID: 33519462
[No Abstract] [Full Text] [Related]
11. Inhibiting ubiquitin conjugating enzyme E2 N by microRNA-590-3p reduced cell growth of cervical carcinoma.
Song TT; Xu F; Wang W
Kaohsiung J Med Sci; 2020 Jul; 36(7):501-507. PubMed ID: 32196955
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling analysis of the role of miR-22 in clear cell ovarian cancer.
Zhen YB; Guo XL; Xu B; Zhao HW; Xu CJ
Neoplasma; 2016; 63(6):856-864. PubMed ID: 27565323
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxel-resistant clone.
Sugimura M; Sagae S; Ishioka S; Nishioka Y; Tsukada K; Kudo R
Oncology; 2004; 66(1):53-61. PubMed ID: 15031599
[TBL] [Abstract][Full Text] [Related]
16. Increased Expression of
Zou R; Xu H; Li F; Wang S; Zhu L
DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631
[TBL] [Abstract][Full Text] [Related]
17. Xiaoaiping injection enhances paclitaxel efficacy in ovarian cancer via pregnane X receptor and its downstream molecules.
Zhang XQ; Ding YW; Chen JJ; Xiao X; Zhang W; Zhou L; Kong QW; Shi MZ; Yang J; Jiang B; Guo C; Han YL
J Ethnopharmacol; 2020 Oct; 261():113067. PubMed ID: 32505840
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of circ_CELSR1 facilitates paclitaxel resistance of ovarian cancer by regulating miR-149-5p/SIK2 axis.
Wei S; Qi L; Wang L
Anticancer Drugs; 2021 Jun; 32(5):496-507. PubMed ID: 33735118
[TBL] [Abstract][Full Text] [Related]
19. Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.
Kim YW; Kim EY; Jeon D; Liu JL; Kim HS; Choi JW; Ahn WS
Drug Des Devel Ther; 2014; 8():293-314. PubMed ID: 24591819
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential key genes associated with ovarian clear cell carcinoma.
Xu Y; Shen K
Cancer Manag Res; 2018; 10():5461-5470. PubMed ID: 30519094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
